Apolipoprotein A2 (APOA2)

Apo-A2; Apolipoprotein A-II; ProapoA-II; Truncated apolipoprotein A-II

SPN	W206
HGNC	601
MGI	88050
PubMed	19901143
RGD	2131
UniProt	P02652
Wiki	APOA2

Apolipoprotein A-II is a protein , which is the second most abundant protein of the high density lipoprotein particles. The protein is found in plasma as a monomer, homodimer, or heterodimer with apolipoprotein D. Defects in this gene may result in apolipoprotein A-II deficiency or hypercholesterolemia.Apolipoprotein A-II, like apolipoprotein A-I (APOA1), is a major apolipoprotein in high density lipoprotein (HDL).

Apolipoprotein A-II is the second most abundant protein of high density lipoprotein particles. Warden et al. (1993) showed that in both mice and humans, the APOA2 gene is linked to a gene that controls plasma levels of apoA-II and that the APOA2 gene or its product influences, by an unknown mechanism, plasma levels of free fatty acids (FFA).

Reference

"Isolation and characterisation of a cDNA encoding the precursor for human apolipoprotein AII."
Biochem. Biophys. Res. Commun. 120:734-740(1984) [PubMed] [Europe PMC] [Abstract]

"Human apolipoprotein A-II: nucleotide sequence of a cloned cDNA, and localization of its structural gene on human chromosome 1."
Biochem. Biophys. Res. Commun. 123:1-7(1984) [PubMed] [Europe PMC] [Abstract]

"Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance."
Nucleic Acids Res. 12:3917-3932(1984) [PubMed] [Europe PMC] [Abstract]

"The human apolipoprotein A-II gene: complete nucleic acid sequence and genomic organization."
Nucleic Acids Res. 13:4597-4608(1985) [PubMed] [Europe PMC] [Abstract]

"The human apolipoprotein AII gene: structural organization and sites of expression."
Nucleic Acids Res. 13:6387-6398(1985) [PubMed] [Europe PMC] [Abstract]

"Molecular cloning and sequence analysis of human apolipoprotein A-II cDNA."
Methods Enzymol. 128:745-752(1986) [PubMed] [Europe PMC] [Abstract]

"Sequence polymorphism at the human apolipoprotein AII gene (APOA2): unexpected deficit of variation in an African-American sample."
Hum. Genet. 111:75-87(2002) [PubMed] [Europe PMC] [Abstract]

"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]

"The DNA sequence and biological annotation of human chromosome 1."
Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract]

"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]

"Isolation and characterization of the tryptic and cyanogen bromide peptides of apoLp-Gln-II (apoA-II), plasma high density apolipoprotein."
J. Biol. Chem. 247:7519-7527(1972) [PubMed] [Europe PMC] [Abstract]

"Cell-free translation of human liver apolipoprotein AI and AII mRNA. Processing of primary translation products."
Hoppe-Seyler's Z. Physiol. Chem. 364:227-237(1983) [PubMed] [Europe PMC] [Abstract]

"A splice-junction mutation responsible for familial apolipoprotein A-II deficiency."
Am. J. Hum. Genet. 46:822-827(1990) [PubMed] [Europe PMC] [Abstract]

"Structure of human apolipoprotein D: locations of the intermolecular and intramolecular disulfide links."
Biochemistry 33:12451-12455(1994) [PubMed] [Europe PMC] [Abstract]

"Cloning and characterization of a novel apolipoprotein A-I-binding protein, AI-BP, secreted by cells of the kidney proximal tubules in response to HDL or ApoA-I."
Genomics 79:693-702(2002) [PubMed] [Europe PMC] [Abstract]

"Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein."
J. Lipid Res. 44:349-355(2003) [PubMed] [Europe PMC] [Abstract]

"Novel mass spectrometric immunoassays for the rapid structural characterization of plasma apolipoproteins."
J. Lipid Res. 44:630-639(2003) [PubMed] [Europe PMC] [Abstract]

"NDRG1 interacts with APO A-I and A-II and is a functional candidate for the HDL-C QTL on 8q24."
Biochem. Biophys. Res. Commun. 332:982-992(2005) [PubMed] [Europe PMC] [Abstract]

"An initial characterization of the serum phosphoproteome."
J. Proteome Res. 8:5523-5531(2009) [PubMed] [Europe PMC] [Abstract]

"Initial characterization of the human central proteome."
BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]

"LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins."
J. Proteome Res. 12:573-584(2013) [PubMed] [Europe PMC] [Abstract]

"An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."
J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]

"Structures of apolipoprotein A-II and a lipid-surrogate complex provide insights into apolipoprotein-lipid interactions."
Biochemistry 41:11681-11691(2002) [PubMed] [Europe PMC] [Abstract]